AtriCure

AtriCure develops, manufactures, and sells surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues. Read more

Michael H. Carrel's photo - President & CEO of AtriCure

President & CEO

Michael H. Carrel

CEO Approval Rating

95/100

Founded:

2000

Status:

PublicIndependent CompanyNASDAQATRC

ATRICURE TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

CardioFocus is AtriCure's #1 rival. CardioFocus was founded in 1990 in Marlborough, Massachusetts. Like AtriCure, CardioFocus also operates in the Health Care Equipment space. CardioFocus generates $140.6M less revenue than AtriCure.

Thermi is one of AtriCure's top competitors. Thermi is headquartered in Irving, Texas, and was founded in 2012. Like AtriCure, Thermi also works within the Health Care Technology sector. Thermi generates 6.12% the revenue of AtriCure.

Kardium is seen as one of AtriCure's top competitors. Kardium was founded in 2007, and its headquarters is in Burnaby, British Columbia. Like AtriCure, Kardium also works within the Health Care Equipment sector. Kardium has 490 fewer employees than AtriCure.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Neograft a competitor of AtriCure?

AtriCure Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$212.6M

AtriCure's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 233.1M. Over the last four quarters, AtriCure's revenue has grown by 45.2%. Specifically, in Q1 2021's revenue was $59.3M; in Q4 2020, it was $57.7M; in Q3 2020, it was $54.8M; in Q2 2020, AtriCure's revenue was $40.8M.

AtriCure Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
SentreHEART, Inc.

Aug 2019

Source »
$40M
SentreHEART develops, manufactures and delivers remote suture delivery and tissue closure devices.

-

-

Oct 2015

Source »
$99M
-
Endoscopic Technologies, Inc.

Dec 2013

Source »
$60M
Estech develops and markets medical devices and disposables focusing on minimally invasive cardiac procedures.

These are all the companies that AtriCure has acquired. AtriCure has acquired 3 companies and its latest acquisition was SentreHEART, Inc. in Aug 2019. SentreHEART develops, manufactures and delivers remote suture delivery and tissue closure devices.

AtriCure Funding History

Since AtriCure was founded in 2000, it has participated in 2 rounds of funding. In total AtriCure has raised $53.0M. AtriCure's last funding round was on Aug 2005 for a total of $48.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Aug 2005
$48M
-
Venture Round
Jun 2001
$5M

Partisan Management Group

Since AtriCure was founded in 2000, it has participated in 2 rounds of funding. In total AtriCure has raised $53.0M. AtriCure's last funding round was on Aug 2005 for a total of $48.0M

AtriCure Investments

No recent investments found related to AtriCure

These are all the companies that AtriCure has invested in. AtriCure has invested 3 companies and its latest investment was SentreHEART, Inc. in Aug 2019. SentreHEART develops, manufactures and delivers remote suture delivery and tissue closure devices.

AtriCure News

April 30, 2021NS Medical Devices

FDA approves AtriCure's EPi-Sense system to treat persistent atrial fibrillation

The post FDA approves AtriCure's EPi-Sense system to treat persistent atrial fibrillation appeared fi... See more »
April 27, 2021Markets Insider

AtriCure Reports First Quarter 2021 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and l... See more »
April 6, 2021BioSpace

AtriCure to Announce First Quarter 2021 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and... See more »
February 23, 2021BioSpace

AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results

AtriCure, Inc., a leading innovator in treatments for atrial fibrillation and left atrial appendage m... See more »
February 10, 2021Markets Insider

AtriCure to Participate at the SVB Leerink 10th Annual Global Healthcare Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Af... See more »
February 2, 2021BioSpace

AtriCure to Announce Fourth Quarter and Full Year 2020 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and... See more »
January 20, 2021Medical Product Outsourcing

AtriCure Receives FDA Clearance to Expand its Labeling for Cryo Nerve Block Therapy

The expansion includes adolescent patients who can benefit from cryo nerve block therapy during surgi... See more »

AtriCure Press Releases

November 19, 2020Business Wire

AtriCure to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatmen... See more »
November 5, 2020Business Wire

AtriCure Reports Third Quarter 2020 Financial Results

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for at... See more »
September 1, 2020Business Wire

AtriCure to Participate at the Morgan Stanley 18th Annual Global Healthcare Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for at... See more »
April 9, 2018MarketersMedia

AtriCure's Quarterly Revenues Jumped 11.9%; Net Loss Narrowed

Stock Monitor: Akers Biosciences Post Earnings ReportingLONDON, UK / ACCESSWIRE / April 09, 2018 / Ac... See more »
July 27, 2017MarketersMedia

AtriCure, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / July 27, 2017 / AtriCure, Inc. (NASDAQ: ATRC) will be discussing their ea... See more »
March 21, 2017PR Newswire

Global Ablation Technologies Market Expected to Reach $4.73 Billion by 2021 - Rising Incidence of Atrial Fibrillation Across the Globe - Research and Markets

DUBLIN, Mar 22, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the "Ablation... See more »
January 9, 2017Business Wire

AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2016

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for at... See more »

AtriCure Videos

Social Media

AtriCure Headquarters

7555 Innovation Way

Mason, Ohio45040

1-513-755-4100

Driving Directions »

Trending Companies

AtriCure Summary

ABOUT

Overview

AtriCure develops, manufactures, and sells surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues. AtriCure was founded in 2000. AtriCure's headquarters is located in Mason, Ohio, USA 45040. It has raised 53.0M in 2...

CEO

AtriCure's President & CEO, Michael H. Carrel, currently has an approval rating of 95%. AtriCure's primary competitors are CardioFocus, Thermi & Kardium.

Frequently Asked Questions about AtriCure

  1. When was AtriCure founded?

    AtriCure was founded in 2000
  2. Who is AtriCure's CEO?

    AtriCure's CEO is Michael H. Carrel
  3. How much revenue does AtriCure generate?

    AtriCure generates $212.6M in revenue
  4. How much funding does AtriCure have?

    AtriCure has historically raised $53M in funding
  1. Where is AtriCure's headquarters?

    AtriCure's headquarters is in Mason Ohio, USA
  2. How many employees does AtriCure have?

    AtriCure has 620 employees
  3. What sector does AtriCure operate in?

    AtriCure is in Health Care Equipment, Health Care Technology
  4. Who are AtriCure's competitors?

    AtriCure's top competitors are CardioFocus, Thermi, Kardium